Director of Business Development, Industry Relations and Technology Transfer at Fred Hutchinson Cancer Research Center
Greater Seattle Area
- Current
-
- Director of Business Development; Industry Relations, and Technology Transfer at Fred Hutchinson Cancer Research Center
- Past
-
- Scientific Director, Marketing & Business Development at Nastech Pharmaceutical Company Inc.
- College Instructor, Consultant at Adnavance Technologies & Shoreline Community College
- Sr. Dir. Strategic Alliances, Sr. Dir. Pharmacology at MDS Pharma Services
- Sr. Scientist at Panlabs, Inc.
- Sr. Scientist at California Biotechnology (Scios/J&J)
- Post-Doctoral Fellow at Salk Institute
- Postdoctoral Fellow at The Salk Institute
- Education
-
- The Salk Institute for Biological Studies
- University of Minnesota-Twin Cities
- University of California, Santa Cruz
- Recommended
-
12 people have recommended Richard - Connections
-
500+
connections
- Industry
- Pharmaceuticals
- Websites
Richard Mitchell’s Summary
•Business strategy and development
•Technology licensing and company acquisitions
•Marketing, competitive intelligence
•Outstanding presentation skills
•Skilled at establishing collaborations, partnerships, consultancies
•Medical Science liason facilitating technical, medical, scientific, and academic communication
•College teaching experience
•Technology due diligence (drug delivery, diagnostics, therapeutics) and intellectual property acquisitions
•Expertise in microbiology, molecular virology and oncology, molecular pharmacology, drug delivery, and drug discovery/development (small molecule and peptide therapeutics)
•siRNA target selection and delivery for viral infections, cancer, inflammation and immunomodulation targets
Richard Mitchell’s Experience
-
Director of Business Development; Industry Relations, and Technology Transfer
Fred Hutchinson Cancer Research Center
(Non-Profit; 1001-5000 employees; Research industry)
May 2008 — Present (1 year 7 months)
- Lead in the creation of new ventures based on technologies originating from Fred Hutchinson Cancer Research Center (FHCRC) faculty.
- Responsible for finding new business opportunities and technologies to address identified opportunities, both from within FHCRC and from external sources (including academic and industrial).
- Patent assessment and licensing opportunities
- Development of Tech Transfer strategies
- Provide guidance and oversee Business Development activities of the Office of Industry Relations and Technology Transfer -
Scientific Director, Marketing & Business Development
Nastech Pharmaceutical Company Inc.
(Public Company; 201-500 employees; NSTK; Pharmaceuticals industry)
April 2006 — April 2008 (2 years 1 month)
Articulate professional with demonstrated success in forging partnerships with pharma & biotech companies & academics to solve technical and medical needs. Experienced educator and public speaker , liaison between lab, business, and academic leaders.
STRATEGIC PLANNING & IMPLEMENTATION
• Business strategy and development
• Technology licensing and company acquisitions
• Marketing, competitive intelligence
• Outstanding presentation skills
• Establish collaborations, partnerships, consultancies
• Technical, medical, scientific, and academic liaison with college teaching experience
• Due diligence of technology, therapeutics, and intellectual property acquisitions
• Expertise in microbiology, molecular virology and oncology, molecular pharmacology, drug delivery, and drug discovery/development technologies - small molecule and peptide therapeutics
• siRNA target selection and siRNA delivery for viral infections, cancer, inflammation and immunomodulation targets -
College Instructor, Consultant
Adnavance Technologies & Shoreline Community College
(Privately Held; 1-10 employees; Biotechnology industry)
January 2006 — April 2006 (4 months)
- Taught full-time Recombinant DNA Technologies course at Shoreline Community College in Shoreline, WA
- Accepted to faculty pool at Cascadia Community College and Shoreline Community College to teach Biology, Physiology, and related courses.
- Consulted for Adnavance Technologies
- In-depth evaluation of infectious disease targets for an ultra-rapid DNA diagnostic technology employing "M-DNA", an electrochemical DNA detection technology.
- Consulted for Paracelsus Technogies
- Consultation on vaccine targets for an "M-DNA"-enabled vaccine technology
*NOTE* - Offered position of VP of Business Development for Adnavance following consulting role based on my capabilities and quality of work. -
Sr. Dir. Strategic Alliances, Sr. Dir. Pharmacology
MDS Pharma Services
(Public Company; 5001-10,000 employees; MDZ; Biotechnology industry)
January 2000 — October 2005 (5 years 10 months)
Sr. Dir., Strategic Alliances 2004 - 2005
Sr. Dir. of Pharmacology 2000 - 2004
Dr. of Pharmacology, Pharmacology Product Team Leader 1995 - 2000
Principal Scientist, 1991 - 1995
Sr. Scientist 1990 - 1991
Pharmacology Product Team Leader, grew revenues >15-fold
Identified acquisition opportunities for MDS.
Skeletech Inc.; ~$10 MM (2005)
Signature Biosciences Cellular Dielectric Spectroscopy (CellKeyTM) technology by MDS Sciex.
Identified, negotiated, guided collaborations
Iconix Pharmaceuticals-MDS PS Chemoinformatics Database Collaboration, Member, Collaboration Management Board.
BioSource - MDS PS Strategic Alliance - 2005
Becton Dickenson (BD)-MDS Pharma Services Biomarker Alliance, identified BD as a potential Alliance partner.
Secured, managed MDS PS major pharmaceutical/biotech company clients, served as technical liaison.
Lead assay development team (8 staff), (staff developed & validated >300 pharmacology assays)
Co-inventor on 3 patents -
Sr. Scientist
Panlabs, Inc.
(Pharmaceuticals industry)
1990 — 2005 (15 years )
-
Sr. Scientist
California Biotechnology (Scios/J&J)
(Pharmaceuticals industry)
1986 — 1990 (4 years )
-
Post-Doctoral Fellow
Salk Institute
(Pharmaceuticals industry)
1983 — 1986 (3 years )
-
Postdoctoral Fellow
The Salk Institute
(Pharmaceuticals industry)
1983 — 1986 (3 years )
Richard Mitchell’s Education
-
The Salk Institute for Biological Studies
Post-Doctoral , Molecular Oncology (Inder Verma, Sponsor) , 1983 — 1986
Research on the cellular oncogene fos (and also fms), demonstrating rapid regulation of fos transcription during changes in cellular differentiation and other metabolic changes.
Publications in Cell and Science (and other journals) -
University of Minnesota-Twin Cities
Ph.D. , Microbiology , 1978 — 1983
-
University of California, Santa Cruz
BA , Biology , 1972 — 1976
Additional Information
Richard Mitchell’s Websites:
Richard Mitchell’s Honors:
•Customer Satisfaction Award, MDS Pharma Services (2002)
•CalBio Professional Recognition Award for Outstanding Achievement (1989)
•Bacaner Research Award (for outstanding thesis) Minn. Med. Foundation, Univ. of Minn. (1985)
•NIH Individual Postdoctoral Fellowship Award, The Salk Institute, San Diego (1984–1987)
•USPHS Predoctoral Fellowship, Dept. of Microbiology, Univ. of Minn. (1978-1982)
•Honors in Biology and College Honors, University of California, Santa Cruz (1976)
